Clinical Trial Update: Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RS [Phase 4]

View source ↗

Summary

Phase 4 trial comparing roxadustat combined with luspatercept versus luspatercept alone in refractory myelodysplastic syndromes with ring sideroblasts (MDS-RS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Luspatercept (luspatercept)
• Roxadustat (roxadustat)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Myelodysplastic Syndromes | Phase 4 | Status: UNKNOWN